Using Machine Learning to Predict Antimicrobial Resistance of Acinetobacter Baumannii, Klebsiella Pneumoniae and

Georgios Feretzakis1,2,3, Aikaterini Sakagianni4, Evangelos Loupelis2

  • 1School of Science and Technology, Hellenic Open University, Patras, Greece.

Insights

Machine learning models can predict antimicrobial resistance in Gram-negative bacteria like Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. This aids in faster empirical antibiotic treatment selection for hospital-acquired infections.

Area of Science:

  • Infectious Diseases
  • Medical Informatics
  • Computational Biology

Background:

  • Hospital-acquired infections (HAIs) are increasing, especially Gram-negative bacterial infections in ICUs.
  • Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa are highly resistant bacteria common in ICUs.
  • Standard antibiotic resistance tests take ~24 hours, delaying empirical treatment.

Purpose of the Study:

  • To evaluate machine learning (ML) models for predicting antimicrobial resistance.
  • To assess the feasibility of using ML as a decision support tool for empirical antibiotic therapy.
  • To forecast antibiotic resistance patterns for key Gram-negative pathogens.

Main Methods:

  • Five distinct machine learning models were assessed.
  • Models predicted antimicrobial resistance for Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
  • Data utilized was sourced from clinical microbiology laboratory information systems (LIS).

Main Results:

  • Machine learning models demonstrated potential in predicting antimicrobial resistance.
  • The study identified ML as a viable tool for supporting clinical decisions.
  • Accurate prediction of resistance can expedite appropriate antibiotic selection.

Conclusions:

  • Implementing ML techniques can enhance antibiotic resistance forecasting.
  • ML integration with LIS data offers a promising approach to combatting resistant Gram-negative infections.
  • This strategy can improve patient outcomes by enabling timely and effective empirical antibiotic treatment.